France· FR:64292898
INVOKANA 100 mg, comprimé pelliculé
A medicinal product containing canagliflozine hémihydraté, registered in France by JANSSEN CILAG INTERNATIONAL NV, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CANAGLIFLOZINE HÉMIHYDRATÉ
- Manufacturer
- JANSSEN CILAG INTERNATIONAL NV
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340092767289730 plaquette(s) thermoformée(s) PVC-Aluminium de 1 comprimé(s)EUR 38.29
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Canagliflozine hémihydraté in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaINVOKANAJanssen-Cilag International N.V., Beerse
- United StatesINVOKANAA-S Medication Solutions
- SpainCANAGLIFLOZINA TEVA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGTeva B.V.
- FinlandCanagliflozin ratiopharmTeva B.V.
- SwitzerlandInvokana
- PolandInvokanaJanssen-Cilag International N.V.
- SwedenInvokana 100 mg Filmdragerad tablettJanssen-Cilag International NV
- IcelandInvokanaJanssen-Cilag International NV*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Invokana
- Liechtenstein · Invokana
- Norway · Invokana
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf938e4b-2ff7-4006-a44b-40a471f69643 GET /v1/drugs/bf938e4b-2ff7-4006-a44b-40a471f69643?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64292898",
"date_amm": "2013-11-15",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/13/884",
"substance": "CANAGLIFLOZINE HÉMIHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about canagliflozine hémihydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.